BE demonstrated in pilot study [Power / Sample Size]

posted by H_Rotter – Germany, 2006-05-20 15:56 (7325 d 23:14 ago) – Posting: # 132
Views: 21,963

Hi Joy,

at least for the USA it should be possible to show BE in a pilot study, because http://www.fda.gov/cder/guidance/5356fnl.pdf FDA states at
III.A.2. Pilot study:
“[…] A pilot study that documents BE can be appropriate, provided its design and execution are suitable and a sufficient number of subjects (e.g., 12) have completed the study.”

But don’t ask me, what ‘sufficient number’ actually means. :confused:

Best regards,
Hermann


Edit: Link corrected to latest archived copy. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
146 visitors (0 registered, 146 guests [including 24 identified bots]).
Forum time: 15:11 CEST (Europe/Vienna)

In theory, there is no difference between theory and practice.
But, in practice, there is.    Jan L.A. van de Snepscheut

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5